Immunotherapies work by leveraging the natural capabilities of the immune system. For instance, monoclonal antibodies can bind to specific targets on cancer cells, marking them for destruction by other immune cells. Checkpoint inhibitors remove the "brakes" from immune cells, enabling them to attack cancer cells more effectively.
